These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8207810)

  • 1. Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation.
    Izumi KM; Kaye KM; Kieff ED
    J Virol; 1994 Jul; 68(7):4369-76. PubMed ID: 8207810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues.
    Kaye KM; Izumi KM; Mosialos G; Kieff E
    J Virol; 1995 Feb; 69(2):675-83. PubMed ID: 7815530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
    Harada S; Yalamanchili R; Kieff E
    J Virol; 1998 Dec; 72(12):9948-54. PubMed ID: 9811732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation.
    Izumi KM; Kaye KM; Kieff ED
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1447-52. PubMed ID: 9037073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
    Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
    J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
    Huen DS; Henderson SA; Croom-Carter D; Rowe M
    Oncogene; 1995 Feb; 10(3):549-60. PubMed ID: 7845680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.
    Kaye KM; Izumi KM; Li H; Johannsen E; Davidson D; Longnecker R; Kieff E
    J Virol; 1999 Dec; 73(12):10525-30. PubMed ID: 10559372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.
    Longnecker R; Miller CL; Miao XQ; Tomkinson B; Kieff E
    J Virol; 1993 Apr; 67(4):2006-13. PubMed ID: 8383224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB.
    Izumi KM; Kieff ED
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12592-7. PubMed ID: 9356494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
    Kaye KM; Izumi KM; Kieff E
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):9150-4. PubMed ID: 8415670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B.
    Longnecker R; Miller CL; Tomkinson B; Miao XQ; Kieff E
    J Virol; 1993 Aug; 67(8):5068-74. PubMed ID: 8392630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    Cohen JI; Wang F; Kieff E
    J Virol; 1991 May; 65(5):2545-54. PubMed ID: 1850028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1.
    Franken M; Devergne O; Rosenzweig M; Annis B; Kieff E; Wang F
    J Virol; 1996 Nov; 70(11):7819-26. PubMed ID: 8892903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
    Tong X; Yalamanchili R; Harada S; Kieff E
    J Virol; 1994 Oct; 68(10):6188-97. PubMed ID: 8083959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-terminal half of EBNA2, except for seven prolines, is not essential for primary B-lymphocyte growth transformation.
    Yalamanchili R; Harada S; Kieff E
    J Virol; 1996 Apr; 70(4):2468-73. PubMed ID: 8642674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.
    Longnecker R; Miller CL; Miao XQ; Marchini A; Kieff E
    J Virol; 1992 Nov; 66(11):6461-9. PubMed ID: 1328675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines.
    Higuchi M; Kieff E; Izumi KM
    J Virol; 2002 Jan; 76(1):455-9. PubMed ID: 11739714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction.
    Fruehling S; Lee SK; Herrold R; Frech B; Laux G; Kremmer E; Grässer FA; Longnecker R
    J Virol; 1996 Sep; 70(9):6216-26. PubMed ID: 8709248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
    Yalamanchili R; Tong X; Grossman S; Johannsen E; Mosialos G; Kieff E
    Virology; 1994 Nov; 204(2):634-41. PubMed ID: 7941331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1.
    Mosialos G; Hanissian SH; Jawahar S; Vara L; Kieff E; Chatila TA
    J Virol; 1994 Mar; 68(3):1697-705. PubMed ID: 8107230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.